Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial
1. Vernakalant was superior to procainamide for rapid cardioversion of patients with acute atrial fibrillation, with a higher conversion rate ...
